| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |